Cleared Traditional

Renovis Tesera C/Tesera SC Anterior Cervical Fusion (ACF) System (K182007) - FDA 510(k) Clearance

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K182007 · Renovis Surgical Technologies · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2018
Decision
133d
Days
Class 2
Risk

K182007 is an FDA 510(k) clearance for the Renovis Tesera C/Tesera SC Anterior Cervical Fusion (ACF) System. Classified as Intervertebral Fusion Device With Integrated Fixation, Lumbar (product code OVD), Class II - Special Controls.

Submitted by Renovis Surgical Technologies (Redlands, US). The FDA issued a Cleared decision on December 7, 2018 after a review of 133 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3080 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Renovis Surgical Technologies devices

Submission Details

510(k) Number K182007 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 27, 2018
Decision Date December 07, 2018
Days to Decision 133 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
11d slower than avg
Panel avg: 122d · This submission: 133d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code OVD Intervertebral Fusion Device With Integrated Fixation, Lumbar
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3080
Definition Intended To Stabilize Lumbar Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft With Or Without Supplemental Fixation.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

MEDIcept, Inc.
Sharyn Orton

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - OVD Intervertebral Fusion Device With Integrated Fixation, Lumbar

All 198
Devices cleared under the same product code (OVD) and FDA review panel - the closest regulatory comparables to K182007.
MectaLIF 3D Metal Anterior
K254202 · Medacta International S.A. · May 2026
Ventana™ A Anterior Lumbar Interbody System
K253559 · Spinal Elements, Inc. · Feb 2026
DeGen Medical Patient Specific Implant (PSI) System
K251829 · Degen Medical · Dec 2025
IdentiTi™ II ALIF Standalone Interbody System
K251575 · Alphatec Spine · Sep 2025
CONDUIT™ SYNFIX™ Evolution Secured Spacer System
K250072 · Avalign Technologies, Inc. · Jul 2025
ProAM ALIF System
K251644 · Pro Surgical, Inc. · Jun 2025